Follow
Komal Saini
Komal Saini
PhD (UIPS, Panjab University); Ex-commonwealth Split-site
Verified email at cgc.edu.in
Title
Cited by
Cited by
Year
Preparation method, Properties and Crosslinking of hydrogel: a review
K Saini
PharmaTutor 5 (1), 27-36, 2017
692017
Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study
V Kakkar, IP Kaur, AP Kaur, K Saini, KK Singh
Drug development and industrial pharmacy 44 (10), 1701-1712, 2018
632018
Nanoceuticals governance and market review
V Kakkar, M Kumar, K Saini
Environmental chemistry letters 16, 1293-1300, 2018
212018
Tetrahydrocurcumin lipid nanoparticle based gel promotes penetration into deeper skin layers and alleviates atopic dermatitis in 2, 4-dinitrochlorobenzene (DNCB) mouse model
K Saini, N Modgill, KK Singh, V Kakkar
Nanomaterials 12 (4), 636, 2022
202022
In vitro physicochemical characterization of nanocarriers: a road to optimization
H Goel, K Saini, K Razdan, RK Khurana, AA Elkordy, KK Singh
Nanoparticle Therapeutics, 133-179, 2022
152022
Sodium alginate–arabinoxylan composite microbeads: preparation and characterization
M Ahuja, M Bhatia, K Saini
Journal of Pharmaceutical Investigation 46, 645-653, 2016
152016
An overview of atopic dermatitis with a focus on nano-interventions
V Kakkar, M Kumar, K Saini
Innovations 1, 2019, 2019
122019
Dithranol: An Insight into its Novel Delivery Cargos for Psoriasis Management
V Kadian, S Kumar, K Saini, V Kakkar, R Rao
Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 12 (2), 82-96, 2020
92020
Nano drug delivery in treatment of oral cancer, a review of the literature
V Kakkar, MK Verma, K Saini, IP Kaur
Current Drug Targets 20 (10), 1008-1017, 2019
92019
Scope of nano delivery for atopic dermatitis
V Kakkar, K Saini
Ann. Pharmacol. Pharm 2, 1038, 2017
82017
Comparison of Therapeutic Efficacy of Nanoformulations of Curcumin vs Tetrahydrocurcumin in Various Disorders
V Kakkar, K Saini, M Saini, M Kumar, P Narula, I Duggal
Nanoformulations in human health: challenges and approaches, 377-401, 2020
72020
Assay and dermatokinetics of tetrahydrocurcumin lipidic nanostructures using reverse phase-high performance liquid chromatography
P Narula, K Saini, M Saini, D Singla, AS Chauhan, V Kakkar
Pharmaceutical Nanotechnology 9 (2), 130-140, 2021
52021
Anti-psoriatic effects of tetrahydrocurcumin lipidic nanoparticles in IMQ induced psoriatic plaque: A research report
K Saini, S Verma, V Kakkar
Journal of Drug Delivery Science and Technology 71, 103301, 2022
32022
Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis
V Kakkar, K Saini, KK Singh
Pharmacological Reports 75 (5), 1066-1095, 2023
22023
Preclinical safety of tetrahydrocurcumin loaded lipidic nanoparticles incorporated into tacrolimus ointment: In vitro and in vivo evaluation
K Saini, C Arora, M Saini, S Sharma, D Chitkara, V Kakkar
Food and Chemical Toxicology 167, 113260, 2022
22022
Optimization and Evaluation of Ketoconazole Loaded Nanostructured Lipid Carriers Employing Microwave-Assisted Technique.
M Bhatia, M Srivastav, S Devi, SK Sharma, V Kakkar, K Saini
Indian Journal of Pharmaceutical Sciences 84 (1), 2022
22022
Pain Management with Topical Aceclofenac Nanosuspension In-Vitro/In-Vivo and Proof of Concept Studies
S Nagpal, P Kumari, K Saini, V Kakkar
Current Drug Therapy 17 (4), 289-304, 2022
12022
Alzheimer’s disease: potential of nanotailored nutraceuticals
V Kakkar, K Saini, S Adlakha, IP Kaur
NanoNutraceuticals, 105-120, 2018
12018
Emerging applications and ongoing challenges in WSN assisted IoT networks
K Kaur, A Kaur, K Sarita, K Saini, S Kour, S Kaur
2024
Usefulness of Lipidic Nanoparticles of Curcumin and Tetrahydrocurcumin for Skin Inflammation: A Comparative Study
K Saini, MK Verma, IP Kaur, V Kakkar
Current Nanoscience 19 (4), 549-558, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20